ExLibris header image
SFX Logo
Title: Role of K63-linked polyubiquitination in NF- B signalling: which ligase catalyzes and what molecule is targeted?
Source:

Journal of Biochemistry [0021-924X] Hayakawa, M yr:2011


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Chu, W. "Tumor necrosis factor." Cancer letters 328.2 (2012): 222-225. Link to SFX for this item
2. Marx, C. "ErbB2 Trafficking and Degradation Associated with K48 and K63 Polyubiquitination." Cancer research 70.9 (2010): 3709-3717. Link to SFX for this item
3. Taguchi, K. "Keap1 degradation by autophagy for the maintenance of redox homeostasis." Proceedings of the National Academy of Sciences of the United States of America 109.34 (2012): 13561-13566. Link to Full Text for this item Link to SFX for this item
4. Adhikari, A. "Diversity of Polyubiquitin Chains." Developmental cell 16.4 (2009): 485-486. Link to SFX for this item
5. Okamoto, H. "Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase." The Journal of biological chemistry 279.6 (2004): 3916-24. Link to SFX for this item
6. Visser, M. "Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study." The journals of gerontology. Series A, Biological sciences and medical sciences 57.5 (2002): 326-32. Link to SFX for this item
7. Tracey, K J J. "Tumor necrosis factor: a pleiotropic cytokine and therapeutic target." Annual Review of Medicine 45.1 (1994): 491-503. Link to Full Text for this item Link to SFX for this item
8. Boujrad, H. "AIF-mediated programmed necrosis - A highly regulated way to die." Cell cycle 6.21 (2007): 2612-2619. Link to SFX for this item
9. Bradley, J R R. "TNF-mediated inflammatory disease." The Journal of pathology 214.2 (2008): 149-160. Link to Full Text for this item Link to SFX for this item
10. Mocellin, S. "Tumor necrosis factor, cancer and anticancer therapy." Cytokine & growth factor reviews 16.1 (2005): 35-53. Link to SFX for this item
11. Visser, M. "Inflammatory markers and loss of muscle mass (sarcopenia) and strength." The American journal of medicine 119.6 (2006): 526-526. Link to SFX for this item
12. Zelová, H. "TNF-α signalling and inflammation: interactions between old acquaintances." Inflammation research 62.7 (2013): 641-51. Link to SFX for this item
13. Varfolomeev, E. "Tumor Necrosis Factor." Cell 116.4 (2004): 491-497. Link to SFX for this item
14. Proskuryakov, S Ya Y. "Immunology of apoptosis and necrosis." Biochemistry (Moscow) 70.12 (2005): 1310-20. Link to SFX for this item
15. Lin, X. "Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation." Cytokine 41.1 (2007): 1-8. Link to SFX for this item
16. Mueller, H. "Tumor necrosis factor as an antineoplastic agent: pitfalls and promises." Cellular and molecular life sciences 54.12 (1998): 1291-1298. Link to Full Text for this item Link to SFX for this item
17. Anderson, G Mark M. "Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer." Current opinion in pharmacology 4.4 (2004): 314-320. Link to SFX for this item
18. Wong, M. "TNFalpha blockade in human diseases: mechanisms and future directions." Clinical immunology 126.2 (2008): 121-136. Link to SFX for this item
19. Takeda, K. "Targeting death-inducing receptors in cancer therapy." Oncogene 26.25 (2007): 3745-57. Link to Full Text for this item Link to SFX for this item
20. Komatsu, M. "p62/SQSTM1/A170: Physiology and pathology." Pharmacological research 66.6 (2012): 457-462. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced